Patients with myelodysplastic/myeloproliferative neoplasms have higher rates of relapse following allogeneic hematopoietic cell transplantation compared to those with MDS: A Brazilian SBTMO/CIBMTR registry analysis [0.03%]
巴西SBTMO/CIBMTR登记数据分析显示，与仅患有骨髓增生异常综合征的患者相比，患有骨髓增生异常/骨髓增生性肿瘤的患者在接受异基因造血细胞移植后的复发率更高
Fernando Barroso Duarte,Yhasmine Delles Oliveira Garcia,Vanderson Rocha et al.
Fernando Barroso Duarte et al.
Pre-transplant azacitidine does not improve survival in allogeneic HSCT for higher-risk MDS [0.03%]
移植前使用地西他滨不能提高高危骨髓增生异常综合征患者的 allo-HSCT 生存率
Miles Horton,Becky Leung,Ricky Nelles et al.
Miles Horton et al.
Outcomes of 544 Patients with t(6;9)/DEK::NUP214 acute myeloid leukemia undergoing allogeneic stem cell transplantation: an EBMT study on behalf of the acute leukemia working party (ALWP) and the pediatric diseases working party (PDWP) [0.03%]
DEK-NUP214阳性急性髓系白血病患者接受异基因造血干细胞移植后预后：ALWP和PDWP合作的一项EBMT研究
Fabio Andreozzi,Jacques-Emmanuel Galimard,Johan Maertens et al.
Fabio Andreozzi et al.
Acute myeloid leukemia (AML) with translocation (6;9)(p23;q34) is a rare and high-risk disease, frequently co-occurring with FLT3-ITD alteration. We retrospectively analyzed 544 patients with t(6;9) AML undergoing allogeneic hematopoietic s...
Outcomes of allogeneic transplantation in blast-phase myeloproliferative neoplasms: one-third achieve long-term survival [0.03%]
异基因移植治疗骨髓增殖性肿瘤的急变期疗效：三分之一患者实现长期生存
Kordelia Barbullushi,Nico Gagelmann,Kristin Rathje et al.
Kordelia Barbullushi et al.
Philadelphia-negative myeloproliferative neoplasms (MPNs) can progress to blast phase (MPN-BP), a biologically distinct and highly lethal entity with a median survival typically under six months. Allogeneic hematopoietic stem cell transplan...
Impact of stem cell source in HLA-matched hematopoietic stem cell transplant for acute lymphoblastic leukemia in first complete remission: a study from the GRAALL and the SFGM-TC [0.03%]
第一代完全缓解急性淋巴细胞白血病患者中HLA配型相合的造血干细胞移植供者来源的影响：GRAALL和SFGM-TC研究组织的研究
Matthieu Jestin,Sébastien Maury,Anne Huynh et al.
Matthieu Jestin et al.
Impact of antiviral therapies on survival in patients with HHV-6B encephalitis after cord blood transplantation: a real-world study [0.03%]
抗病毒治疗对接受脐带血移植后HHV-6B脑炎患者生存影响的回顾性研究
Toshiki Terao,Wataru Kitamura,Takahiro Fujino et al.
Toshiki Terao et al.
In this registry-based study, we evaluated the efficacy of different antiviral therapies for adult patients who developed human herpesvirus-6B (HHV-6B) encephalitis after their first cord blood transplantation (CBT). Among 3,862 CBT recipie...
Anthony D Ho,Peter Dreger,Christopher Juttner et al.
Anthony D Ho et al.
February, 2026 is the 40th anniversary of the 1st publication of rapid recovery of bone marrow function after high-dose chemotherapy and infusion of an autologous blood- rather than a bone-marrow-derived graft. The recipient, a man with adv...
Busulfan pharmacokinetics in adults - a real-world evaluation of intra-individual variability and the impact of obesity and deferasirox [0.03%]
评价成人的真实世界药代动力学-个体内部变异及肥胖和去铁斯罗ックス的影响
Claudia Langebrake,Eva-Maria A Wansing,Dietlinde Janson et al.
Claudia Langebrake et al.
To avoid under- or overexposure caused by a high variability of busulfan's pharmacokinetic parameters, therapeutic drug monitoring (TDM) is highly recommended. Nevertheless, it is not widely used in European transplant centers. We retrospec...
Sequential CD19/CD22 CAR-T cell therapy following ASCT shows improved efficacy versus CAR-T alone in relapsed/refractory large B-cell lymphoma [0.03%]
ASCT后序贯CD19/CD22 CAR-T细胞治疗相较单用CAR-T治疗在复发/难治性大B细胞淋巴瘤中表现出更好的疗效
Jiaqi Li,Shanglong Feng,Sixun Jia et al.
Jiaqi Li et al.
Chronic graft-versus-host disease after haploidentical transplantation in aplastic anemia: clinical characteristics, risk factors, and survival outcomes [0.03%]
单倍型移植后慢性移植物抗宿主病在再生障碍性贫血中的临床特点、危险因素及生存结局分析
Ming-Hao Lin,Sheng-Nan Gao,Xiao-Jun Huang et al.
Ming-Hao Lin et al.
To investigate the clinical characteristics, risk factors, and impacts of chronic graft-versus-host disease (cGvHD) on survival outcomes in patients with severe aplastic anemia (SAA) following haploidentical hematopoietic stem cell transpla...